Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AMD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
TPSAB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MTRR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HIST1H2BC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
ACSL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EEF1A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRSF5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
B4GALT6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARPP19 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BCLAF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SNAI2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ANGPT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UBE2D3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACTG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OVCA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLRA1P - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SGK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on